FDA Orange Book · active-ingredient family
Magnesium sulfate; potassium chloride; sodium sulfate
Magnesium sulfate; potassium chloride; sodium sulfate is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:SUTAB · NDA 213135
1
Brand (NDA)
1
Generics (ANDA)
4
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| SUTABRLD | AZURITY | NDA 213135 | AB | Nov 10, 2020 |
Generic (ANDA) products (1)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| SODIUM SULFATE, MAGNESIUM SULFATE AND POTASSIUM CHLORIDE | LUPIN | ANDA 216095 | AB | May 28, 2026 |
Listed patents (4)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11382864 | Aug 04, 2037 | in 11 yr 3 mo | U-3164 |
| 11033498 | Aug 04, 2037 | in 11 yr 3 mo | U-3164 |
| 11638697 | Aug 04, 2037 | in 11 yr 3 mo | Product |
| 10143656 | Aug 04, 2037 | in 11 yr 3 mo | Product |
Magnesium sulfate; potassium chloride; sodium sulfate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

